It also targets mouse double minute 2 (MDM2) and vascular endothelial growth factor (VEGF) molecules, which are involved in tumor progression and have anticancer effects on human breast cancer (Xiong et al., 2017). The gene discussed is MDM2; the disease is breast carcinoma.